ImageneBio (IMA) Operating Expenses (2020 - 2025)

ImageneBio has disclosed Operating Expenses across 6 years of filings, most recently posting $26.6 million for Q3 2025.

• In Q3 2025, Operating Expenses rose 380.38% year-over-year to $26.6 million; the TTM figure through Sep 2025 stood at $65.4 million (up 5.16% YoY), while the FY2024 annual figure was $59.0 million, down 30.27% from the prior year.
• Operating Expenses came in at $26.6 million for Q3 2025 at ImageneBio, up from $7.4 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $26.6 million in Q3 2025 to a low of $5.5 million in Q3 2024.
• Average Operating Expenses over 5 years is $18.0 million, with a median of $20.3 million recorded in 2022.
• Year-over-year, Operating Expenses sank 73.24% in 2024 and soared 380.38% in 2025.
• Over 5 years, Operating Expenses stood at $17.4 million in 2021, then rose by 18.01% to $20.6 million in 2022, then grew by 9.74% to $22.6 million in 2023, then rose by 9.08% to $24.6 million in 2024, then grew by 8.04% to $26.6 million in 2025.
• Per Business Quant data, the three most recent Operating Expenses figures were $26.6 million in Q3 2025, $7.4 million in Q2 2025, and $6.8 million in Q1 2025.